Published in Alcohol Alcohol on February 03, 2009
Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients. Drug Alcohol Depend (2011) 1.51
Unipolar depression does not moderate responses to the Sweet Taste Test. Depress Anxiety (2010) 0.93
Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep (2012) 0.89
Cocaine self-administration punished by i.v. histamine in rat models of high and low drug abuse vulnerability: effects of saccharin preference, impulsivity, and sex. Physiol Behav (2013) 0.87
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence. Psychopharmacology (Berl) (2011) 0.86
Effects of a diagnosis or family history of alcoholism on the taste intensity and hedonic value of sucrose. Am J Addict (2009) 0.83
Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake. Brain Res (2015) 0.82
Milk consumption during adolescence decreases alcohol drinking in adulthood. Pharmacol Biochem Behav (2009) 0.77
Sweet taste pleasantness is modulated by morphine and naltrexone. Psychopharmacology (Berl) (2016) 0.76
Targeted opioid receptor antagonists in the treatment of alcohol use disorders. CNS Drugs (2013) 0.76
Prenatal ethanol increases sucrose reinforcement, an effect strengthened by postnatal association of ethanol and sucrose. Alcohol (2013) 0.76
Difference of the naltrexone's effects in social drinkers by spicy food preference. J Korean Med Sci (2014) 0.75
Tasting profile affects adoption of caloric beverage reduction in a randomized weight loss intervention. Obes Sci Pract (2016) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
No adjustments are needed for multiple comparisons. Epidemiology (1990) 23.80
Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict (1989) 6.58
Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict (1988) 6.20
Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry (1992) 5.48
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry (2008) 4.91
Neurogenetic adaptive mechanisms in alcoholism. Science (1987) 4.86
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA (2005) 4.64
A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology (2003) 3.66
Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res (1999) 3.63
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review. Addiction (2004) 3.27
Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci (2005) 3.10
Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta-analysis. Alcohol Clin Exp Res (2001) 2.39
Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics (2005) 2.29
Evidence of preference for a high-concentration sucrose solution in alcoholic men. Am J Psychiatry (1997) 2.11
Sweet taste preference as a risk factor for alcohol dependence. Am J Psychiatry (2001) 1.89
Opioid receptor gene (OPRM1, OPRK1, and OPRD1) variants and response to naltrexone treatment for alcohol dependence: results from the VA Cooperative Study. Alcohol Clin Exp Res (2007) 1.86
Understanding US addiction physicians' low rate of naltrexone prescription. Drug Alcohol Depend (2003) 1.86
The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology (2002) 1.66
The Women's Recovery Group Study: a Stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug Alcohol Depend (2007) 1.55
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment. Alcohol Clin Exp Res (2007) 1.53
Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence. Psychopharmacology (Berl) (1997) 1.49
Predicting treatment response to naltrexone: the influence of craving and family history. Am J Addict (2001) 1.46
Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: a meta-analysis of randomized controlled trials. Alcohol Alcohol (2001) 1.44
Alcohol craving predicts drinking during treatment: an analysis of three assessment instruments. J Stud Alcohol (2003) 1.36
A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers. Alcohol Clin Exp Res (2007) 1.33
Association between preference for sweets and excessive alcohol intake: a review of animal and human studies. Alcohol Alcohol (1999) 1.30
Effects of cigarette smoking and family history of alcoholism on sweet taste perception and food cravings in women. Alcohol Clin Exp Res (2007) 1.30
Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry (2005) 1.29
Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism. Arch Gen Psychiatry (1996) 1.26
Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem (2004) 1.23
Pharmacological relapse prevention of alcoholism: clinical predictors of outcome. Eur Addict Res (2005) 1.18
Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am J Clin Nutr (1995) 1.16
Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Biol Psychiatry (2004) 1.12
Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcohol Clin Exp Res (2003) 1.10
Family history of alcoholism and response to sweets. Alcohol Clin Exp Res (2003) 1.10
Naltrexone, relapse prevention, and supportive therapy with alcoholics: an analysis of patient treatment matching. J Consult Clin Psychol (1996) 1.09
Experience of a "slip" among alcoholics treated with naltrexone or placebo. Am J Psychiatry (1996) 1.06
Clinical predictors of response to naltrexone in alcoholic patients: who benefits most from treatment with naltrexone? Alcohol Alcohol (2005) 1.03
The role of craving in alcohol use, dependence, and treatment. Alcohol Clin Exp Res (2001) 1.03
Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol (2000) 0.98
Different pituitary beta-endorphin and adrenal cortisol response to ethanol in individuals with high and low risk for future development of alcoholism. Life Sci (1989) 0.96
Family history and antisocial traits moderate naltrexone's effects on heavy drinking in alcoholics. Exp Clin Psychopharmacol (2007) 0.95
Assessing craving for alcohol. Alcohol Res Health (1999) 0.94
Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry (1995) 0.93
Opioid antagonists for alcohol dependence. Cochrane Database Syst Rev (2002) 0.91
Perceived intensity and pleasantness of sucrose taste in male alcoholics. Alcohol Alcohol (2007) 0.89
Effects of body weight and food intake on pleasantness ratings for a sweet stimulus. J Appl Physiol (1976) 0.88
Taste responses in sons of male alcoholics. Alcohol Alcohol (2001) 0.88
Hedonic response of sucrose likers and dislikers to other gustatory stimuli. Physiol Behav (1992) 0.87
Selective actions of central mu and kappa opioid antagonists upon sucrose intake in sham-fed rats. Brain Res (1995) 0.87
Morphine and acceptability of putative reinforcers. Pharmacol Biochem Behav (1983) 0.84
Same genetic components underlie different measures of sweet taste preference. Am J Clin Nutr (2007) 0.82
Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry (2005) 5.72
Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychol (2006) 5.48
Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry (2005) 3.46
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst (2002) 3.25
Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry (2011) 2.88
Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res (2010) 2.70
Underuse of lung protective ventilation: analysis of potential factors to explain physician behavior. Crit Care Med (2006) 2.64
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. Int J Cancer (2006) 2.41
Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization. Ann Surg Oncol (2003) 2.06
The dependability of alliance assessments: the alliance-outcome correlation is larger than you might think. J Consult Clin Psychol (2011) 2.00
A simple clinical predictive index for objective estimates of mortality in acute lung injury. Crit Care Med (2009) 1.91
Attachment-based family therapy for adolescents with suicidal ideation: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry (2010) 1.82
Preventing depression among early adolescents in the primary care setting: a randomized controlled study of the Penn Resiliency Program. J Abnorm Child Psychol (2006) 1.79
Prediction of response to medication and cognitive therapy in the treatment of moderate to severe depression. J Consult Clin Psychol (2009) 1.67
ANGPT2 genetic variant is associated with trauma-associated acute lung injury and altered plasma angiopoietin-2 isoform ratio. Am J Respir Crit Care Med (2011) 1.62
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. J Clin Oncol (2005) 1.58
School-based prevention of depressive symptoms: A randomized controlled study of the effectiveness and specificity of the Penn Resiliency Program. J Consult Clin Psychol (2007) 1.57
Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma. Ann Am Thorac Soc (2014) 1.57
Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol (2002) 1.56
Health-related quality of life in patients with pulmonary arterial hypertension. Respir Res (2005) 1.55
Therapists as fixed versus random effects-some statistical and conceptual issues: a comment on Siemer and Joormann (2003). Psychol Methods (2003) 1.52
Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. Br J Psychiatry (2008) 1.44
The impact of development of acute lung injury on hospital mortality in critically ill trauma patients. Crit Care Med (2008) 1.38
Relation of depression diagnoses to 2-year outcomes in cocaine-dependent patients in a randomized continuing care study. Psychol Addict Behav (2002) 1.34
Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug Alcohol Depend (2008) 1.29
Treatment preferences affect the therapeutic alliance: implications for randomized controlled trials. J Consult Clin Psychol (2007) 1.28
Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res (2004) 1.21
Age at menarche and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers. Cancer Causes Control (2005) 1.20
The psychometric properties of the MASC in a pediatric psychiatric sample. J Anxiety Disord (2006) 1.18
The alliance in motivational enhancement therapy and counseling as usual for substance use problems. J Consult Clin Psychol (2009) 1.16
Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry (2013) 1.15
Causal Mediation Analyses for Randomized Trials. Health Serv Outcomes Res Methodol (2008) 1.15
Unique and common mechanisms of change across cognitive and dynamic psychotherapies. J Consult Clin Psychol (2009) 1.14
Extreme nonresponse in cognitive therapy: can behavioral activation succeed where cognitive therapy fails? J Consult Clin Psychol (2007) 1.13
Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict (2002) 1.12
The relation of patients' treatment preferences to outcome in a randomized clinical trial. Behav Ther (2007) 1.10
Objectively identifying landmark use and predicting flight trajectories of the homing pigeon using Gaussian processes. J R Soc Interface (2010) 1.09
Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir Med (2008) 1.09
HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr (2003) 1.09
Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. J Consult Clin Psychol (2007) 1.08
IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist. Am J Respir Crit Care Med (2013) 1.03
What aspects of treatment matter to the patient in the treatment of cocaine dependence? J Subst Abuse Treat (2004) 1.02
An alternative method of acute lung injury classification for use in observational studies. Chest (2010) 1.02
Long-term effects of brief acceptance and commitment therapy for psychosis. Behav Modif (2011) 1.02
Spontaneous and therapeutic abortions and the risk of breast cancer among BRCA mutation carriers. Breast Cancer Res (2006) 1.01
Wide variation in clinicians' assessment of New York Heart Association/World Health Organization functional class in patients with pulmonary arterial hypertension. Mayo Clin Proc (2009) 1.01
Preventing depression: a randomized trial of interpersonal psychotherapy-adolescent skills training. Depress Anxiety (2010) 1.01
A randomized controlled study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat (2010) 0.98
African American race, obesity, and blood product transfusion are risk factors for acute kidney injury in critically ill trauma patients. J Crit Care (2012) 0.97
Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol (2002) 0.97
Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. J Clin Psychiatry (2008) 0.96
Sweet liking and high novelty seeking: independent phenotypes associated with alcohol-related problems. Alcohol Alcohol (2010) 0.96
Mother-child conflict and its moderating effects on depression outcomes in a preventive intervention for adolescent depression. J Clin Child Adolesc Psychol (2009) 0.95
Differential relationships between personal and community stressors and children's neurocognitive functioning. Child Maltreat (2008) 0.94
Social, emotional, and academic competence among children who have had contact with child protective services: prevalence and stability estimates. J Am Acad Child Adolesc Psychiatry (2007) 0.93
Unipolar depression does not moderate responses to the Sweet Taste Test. Depress Anxiety (2010) 0.93
Multilevel modeling of longitudinal data for psychotherapy researchers: I. The basics. Psychother Res (2009) 0.92
How many treatment sessions and patients are needed to create a stable score of adherence and competence in the treatment of cocaine dependence? Psychother Res (2012) 0.92
A generalizability theory analysis of group process ratings in the treatment of cocaine dependence. Psychother Res (2011) 0.91
Dialectical behavior therapy (DBT) applied to college students: a randomized clinical trial. J Consult Clin Psychol (2012) 0.90
Additional treatment services in a cocaine treatment study: level of services obtained and impact on outcome. Am J Addict (2008) 0.89
A feasibility study of a web-based performance improvement system for substance abuse treatment providers. J Subst Abuse Treat (2007) 0.89
Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend (2008) 0.89
Combined medication and cognitive therapy for generalized anxiety disorder. J Anxiety Disord (2011) 0.89
Identification of Sonographic B-lines with Linear Transducer Predicts Elevated B-Type Natriuretic Peptide Level. West J Emerg Med (2011) 0.88
A preliminary study of the effects of individual patient-level feedback in outpatient substance abuse treatment programs. J Subst Abuse Treat (2011) 0.87
Breast cancer subtypes in Asian-Americans differ according to Asian ethnic group. J Immigr Minor Health (2012) 0.87
Sequence of improvement in depressive symptoms across cognitive therapy and pharmacotherapy. J Affect Disord (2008) 0.87
Manualized supportive-expressive psychotherapy versus nonmanualized community-delivered psychodynamic therapy for patients with personality disorders: bridging efficacy and effectiveness. Am J Psychiatry (2005) 0.86
Mediators of outcome of psychosocial treatments for cocaine dependence. J Consult Clin Psychol (2003) 0.86
Effects of family violence on psychopathology symptoms in children previously exposed to maltreatment. Child Dev (2008) 0.85
The development of an independent rater system to assess residents' competence in invasive procedures. Acad Med (2009) 0.84
Psychotherapies for Panic Disorder: A Tale of Two Sites. J Clin Psychiatry (2016) 0.84
Sudden gains in the treatment of generalized anxiety disorder. J Clin Psychol (2008) 0.83
Psychosocial treatments for cocaine dependence: the role of depressive symptoms. Drug Alcohol Depend (2011) 0.83
Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behav Res Ther (2013) 0.83
An open trial of mindfulness-based cognitive therapy for the prevention of perinatal depressive relapse/recurrence. Arch Womens Ment Health (2014) 0.82
The influence of parental factors on therapist adherence in multi-systemic therapy. J Abnorm Child Psychol (2010) 0.82
Program, counselor, and patient variability in the alliance: a multilevel study of the alliance in relation to substance use outcomes. J Subst Abuse Treat (2011) 0.82
An independent randomized clinical trial of multisystemic therapy with non-court-referred adolescents with serious conduct problems. J Consult Clin Psychol (2013) 0.82
Predictors and moderators of outcomes of HIV/STD sex risk reduction interventions in substance abuse treatment programs: a pooled analysis of two randomized controlled trials. Subst Abuse Treat Prev Policy (2014) 0.82
The associations among improvement and alliance expectations, alliance during treatment, and treatment outcome for major depressive disorder. Psychother Res (2014) 0.82
Changes in psychotherapy utilization among consumers of services for major depressive disorder in the community mental health system. Adm Policy Ment Health (2011) 0.81
Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses. Drug Alcohol Depend (2009) 0.81
Sexual trauma history does not moderate treatment outcome in Attachment-Based Family Therapy (ABFT) for adolescents with suicide ideation. J Fam Psychol (2012) 0.81
Baclofen for alcoholism. Lancet (2007) 0.81
Process predictors of the outcome of group drug counseling. J Consult Clin Psychol (2012) 0.80
Minute ventilation recovery time measured using a new, simplified methodology predicts extubation outcome. J Intensive Care Med (2008) 0.80
Interpersonal Psychotherapy-Adolescent Skills Training: Effects on School and Social Functioning. School Ment Health (2012) 0.80
Nonsurgical evaluation of pathologic nipple discharge. Ann Surg Oncol (2003) 0.80
Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants. Biol Psychiatry (2004) 0.79
Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial. J Clin Psychiatry (2007) 0.79
Psychotherapies for panic disorder: a tale of two sites. J Clin Psychiatry (2015) 0.79
Adapting dialectical behavior therapy for outpatient adult anorexia nervosa--a pilot study. Int J Eat Disord (2014) 0.79
Do Personality Problems Improve During Psychodynamic Supportive-Expressive Psychotherapy? Secondary Outcome Results From a Randomized Controlled Trial for Psychiatric Outpatients with Personality Disorders. Psychotherapy (Chic) (2009) 0.79
Assessment of anxiety and depression in primary care: value of a four-item questionnaire. J Am Osteopath Assoc (2009) 0.78
Attenuation of morphine tolerance after antisense oligonucleotide knock-down of spinal mGluR1. Br J Pharmacol (2002) 0.78
Changes in Positive Quality of Life over the Course of Psychotherapy. Psychotherapy (Chic) (2008) 0.78